Trials / Withdrawn
WithdrawnNCT00490113
A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria
Effects of Pyridoxamine on Oxalate Excretion in Stone Disease and Hyperoxaluria
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine whether pyridoxamine can decrease oxalate excretion in subjects who have normal oxalate excretion (but who have had kidney stones), and in subjects who have primary hyperoxaluria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pyridoxamine | Two 250 mg capsules, or placebo, given twice a day for four, 4 week periods. Subjects with primary hyperoxaluria will aslo receive escalated doses up to 3500 mg/day for up to 6 1/2 days. |
Timeline
- Start date
- 2007-01-01
- First posted
- 2007-06-22
- Last updated
- 2017-01-05
Source: ClinicalTrials.gov record NCT00490113. Inclusion in this directory is not an endorsement.